Overview

Duloxetine Role in Reducing Opioid Consumption After Thoracotomy

Status:
Completed
Trial end date:
2020-01-31
Target enrollment:
Participant gender:
Summary
A total of 60 patients scheduled for thoracotomy with the aim of excision of pleural or lung cancer, will be randomized by the use of a computer-generated table of random numbers to receive duloxetine 60 mg orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure or a placebo pill following the same time schedule.
Phase:
Phase 4
Details
Lead Sponsor:
Assiut University
Treatments:
Duloxetine Hydrochloride